CompanyWuXi AppTec, Inc.
China
WuXi AppTec is a global pharmaceutical, biopharmaceutical and medical device outsourcing company. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services across the discovery-to-commercialization spectrum. Their services are designed to assist the customers worldwide in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions.
The company has 4 seperate service facilities in China, United States of America.
Private/Public:
public
Phone:+86-21-5046-1111
Fax:+86-21-5046-1000
Email:[email protected]
Website:http://www.wuxiapptec.com/
Address:288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China
2000
Since
4
facilities at 2 Countries
16
Top Service Categories
569
Sub-Service Categories
Top Services
Molecule Types
For Services/Products
Therapeutic Categories
Main Disease Areas
Business Sectors
For Services/Products
Routes
For Services/Products
ADME/PK
Service Types ADME
API/Biologicals Production
API/Biologics development and manufacturing
- API development phases/scales
- API process capabilities
- API process equipment
- API reactions
- Biologics development and manufacturing
Reagents/excipients manufactured
Diagnostics
Diagnostic services/equipment
Formulation
Formulation development related
Formulation types
Manufacturing Equipment
Package and Label
Specific Services - Packaging etc.
Research Supplies
Life Sciences Supplies/Reagents
Analytical
Analytical Equipment
Analytical lab services
- Sample Type
- Service Type
- CMC analytical- Protein/Peptide/DNA/Oligo
- Antibody sequencing
- Antigen & antibody purity
- Binding assays
- Biological QC testing (Cell-based assay)
- Biosimilar comparability testing
- Chromatography (SEC, IEC)
- Electrophoresis (SDS-PAGE, IF, CE)
- Gene therapy testing/QC release
- Peptide/protein mapping
- Peptide/protein primary structure
- Protein aggregation/deaggregation
- Protein biophysical characterization
- Protein chemical stability
- Vaccine products testing/QC release
- Viral clearance testing
- Medical Device Analysis
- Methods
- Process analytical technology
- Reference standard certification
- Structure elucidation
- Test - Release
- Test-Identity
- Test-Instrumental
- Tests - Dissolution
- Tests - Physical
- Tests - Purity Related
- Tests - Stability
- Tests-Packaging Related
- Tests/Analysis - Other
- CMC analytical- Protein/Peptide/DNA/Oligo
Bioanalytical
Bioanalytical assays
- Biochemical assays
- Biological specimen logistics/management
- Biomarker Discovery and Assays
- GLP/Pre-GLP bioanalysis
- Immunoassays bioanalytical
- Instrumental/label free analysis
- Proteomics/Protein profiling
Discovery and Preclinical
Specific Services-Discovery
- Antibody/proteomics discovery
- Bioinformatics/Informatics
- Chemistry/biology discovery
- Computational Chemistry
- Drug discovery
- Efficacy In vitro
- Efficacy In vivo
- Animal Models
- Cancer models in vivo
- Cardiovascular models in vivo
- CNS models in vivo
- Infection models in vivo
- Inflammation/immune In vivo
- Metabolic models in vivo
- Musculoskeletal models in vivo
- Respiratory disease models in vivo
- Skin disease models in vivo
- Urogenital models in vivo
- Ex Vivo Efficacy/Safety
Genomics
Genomic Services
Preformulation
Preformulation Services
Supply Chain
Supply Chain Management
Consultant
Areas of Expertise
Microbiology
Specific Services - microbiology
- Antimicrobial efficacy testing
- Bacterial Endotoxin Testing
- Bioburden Testing
- Growth Promotion Testing
- Inoculated product
- Microbial challenge test
- Microbial Identification
- Microbial Ingress / Immersion Challenge
- Microbial limit testing
- Mycoplasma Testing
- Sterilization process/equipment
- Whole Package Microbial Aerosol Challenge with Sterility Test
- Whole Package Microbial Talc Challenge with Sterility Test
Regulatory
Regulatory Services
Toxicology
Specific Services-Toxicology
| Facility Type | Address | Telephone | City | Fax | Country | State Code | Service Categories | Facility Size | Year Built | Number Of Employees | Note |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D/Innovation Centers,Manufacturing Facilities,Regional/Country Headquarters | 9765 Clairemont Mesa Blvd, Suite C San Diego, CA 92124 | +1 (858) 622-0099 | San Diego | United States of America | CA-California | ||||||
| Manufacturing Facilities,Regional/Country Headquarters | 6 Cedarbrook Drive, Cranbury NJ 08512 | +1 (609) 799-2295 | Cranbury | United States of America | NJ-New Jersey | ||||||
| Manufacturing Facilities,Regional/Country Headquarters | 107 Morgan Lane, Plainsboro New Jersey 08536 | +1 (609) 799-2295 | Plainsboro | United States of America | |||||||
| R&D/Innovation Centers,Regional/Country Headquarters | 5301 Southwest Parkway, Suite 100 Austin, TX 78735 | +1 (512) 343-1092 | Austin | United States of America | TX-Texas | ||||||
| Regional/Country Headquarters | (Sampyeong-dong, U space 1), B-dong 705-ho, 660, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494 | +82-31-724-2862 | Gyeonggi-do | South Korea | |||||||
| Regional/Country Headquarters | Am Klopferspitz 19a82152 Planegg-Martinsried | +49 (0) 89700760200 | Planegg-Martinsried | Germany | |||||||
| Regional/Country Headquarters | 14 Shenkar Street,4th Floor Herzaliya 4672514 | +972-548085692 | Herzaliya | Israel | |||||||
| Regional/Country Headquarters | 55 Cambridge Parkway Cambridge, MA 02142 | +1 (617) 945-8043 | Cambridge | United States of America | MA-Massachusetts | ||||||
| R&D/Innovation Centers,Manufacturing Facilities | A area 1719-6, Huishan Avenue, Huishan Economic Development Zone, Wuxi, Jiangsu | +86 (510) 8858-3666 | Jiangsu | China | |||||||
| R&D/Innovation Centers,Manufacturing Facilities | 6114 Nancy Ridge Drive, San Diego, CA, 92121, USA | +1 (609)609-6504 | San Diego | United States of America | CA-California | ||||||
| R&D/Innovation Centers,Manufacturing Facilities | 2540 Executive Drive St. Paul, MN 55120 | +1 (651) 675-2000 | St. Paul | United States of America | MN-Minnesota | ||||||
| R&D/Innovation Centers,Manufacturing Facilities | 4701 League Island Blvd Philadelphia, PA 19112 | +1 (215) 218-5500 | Philadelphia | United States of America | PA-Pennsylvania | ||||||
| R&D/Innovation Centers,Manufacturing Facilities | 4751 League Island Blvd Philadelphia, PA 19112 | +1 (215) 218-5500 | Philadelphia | United States of America | PA-Pennsylvania | ||||||
| Manufacturing Facilities | 9 Yuegong Road, Jinshan District Shanghai 201507 | +86 (21) 6725-6015 | Shanghai | China | |||||||
| Manufacturing Facilities | 589 North Yulong Road, Xinbei District, Changzhou, Jiangsu, 213127 | +86 (519) 8128-7118 | Jiangsu | China | |||||||
| Manufacturing Facilities | No.1 Hengfei Road,Economic & Technological Development Zone, Nanjing | +86 (25) 6698-7059 | Nanjing | China | |||||||
| Manufacturing Facilities | 319 Qingpi Avenue, Wenjiang District, Chengdu, Sichuan | +86 (28) 6495-6666 | Sichuan | China | |||||||
| Manufacturing Facilities | 4000 S 26th St Philadelphia, PA 19112 | +1 (215) 218-5500 | Philadelphia | United States of America | PA-Pennsylvania | ||||||
| R&D/Innovation Centers | 8F&19F SOHO, Building A, No. 388, Madang Road, Huangpu District, Shanghai | +86 (21) 2315-8000 | Shanghai | China | |||||||
| R&D/Innovation Centers | 803 SOHO, Building A, No. 388, Madang Road,Huangpu District, Shanghai | +86 (21) 5306-1011 | Shanghai | China | |||||||
| R&D/Innovation Centers | 8 Floors, Block C, Zhaotai International Center, Chaoyang District, Beijing | +86 (10) 6553-3612 | Beijing | China | |||||||
| R&D/Innovation Centers | 666 Gaoxin Road East Lake High-tech Development Zone Wuhan 430075 | +86 (27) 6539-0001 | Wuhan | China | |||||||
| R&D/Innovation Centers | 168 Nanhai Road Tianjin Economic-Technological Development Area(TEDA) | +86 (22) 5998-7288 | Tianjin | China | |||||||
| R&D/Innovation Centers | 1318 Wuzhong Avenue, Wuzhong District, Suzhou, 215104 | +86 (512) 6603-7138 | Suzhou | China | |||||||
| R&D/Innovation Centers | 699 Huashi Nan Road, Qidong Economic Development Zone, Nantong | +86 (513) 8339-3066 | Nantong | China | |||||||
| R&D/Innovation Centers | 10355 Science Center Drive, Suite 260 La Jolla, CA 92121, U.S. | +1 (858) 888-7888 | La Jolla | United States of America | CA-California | ||||||
| R&D/Innovation Centers | 1265 Kennestone Circle Marietta,Atlanta GA 30066 | +1 (770) 514-0262 | Atlanta | United States of America | GA-Georgia | ||||||
| Global Corporate Headquarters | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131 | +86-21-5046-1111 | Shanghai | +86-21-5046-1000 | China |
- (13.Apr.2021) WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award From IMAPAC
- (07.Apr.2021) Endevica Bio Begins IND-Enabling Toxicology Studies
- (06.Apr.2021) WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
- (30.Mar.2021) WuXi AppTec Reports Strong 2020 Annual Results
- (16.Mar.2021) WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19
- (16.Mar.2021) WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities From Pfizer China
- (15.Mar.2021) BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins for Its SARS-CoV-2 Vaccine and COVID-T Immunodiagnostic Programs
- (08.Mar.2021) Exelixis Enters Into Exclusive License Agreement With WuXi Biologics to Support Further Expansion of Its Growing Oncology Biologics Pipeline
- (05.Mar.2021) WuXi ATU and WuXi ATU Have Reached a Strategic Cooperation in the Development and Production of CAR-T New Drug CNCT19 Cell Injection Biological Products on the Market (BLA) Stage
- (03.Mar.2021) Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility
- (02.Mar.2021) WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
- (25.Feb.2021) 2021, WuXi STA Again Wins CMO Leadership Awards in All Six Core Categories
- (12.Feb.2021) Quanterix Announces Simoa Joint Laboratory with WuXi AppTec
- (08.Feb.2021) The World's Largest 36,000L Biomanufacturing Line Using Single-Use Bioreactors Launches GMP Operation at WuXi Biologics
- (02.Feb.2021) WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
- (07.Jan.2021) Genuity Science and Emory University Announce Key Research Agreement Collaboration Designed to Speed Insights Into Major Neurodegenerative Diseases
- (28.Dec.2020) WuXi Biologics Receives GMP Certification From Brazil's ANVISA
- (25.Dec.2020) WuXi STA's Integrated CMC Platform Supports InnoCare's Orelabrutinib Approved by NMPA
- (02.Dec.2020) WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-Stage Innovation and Clinical Research
- (19.Nov.2020) IPS Successfully Delivers a Fast-Paced Project Amid COVID-19
- (18.Nov.2020) WuXi Advanced Therapies Expands Philadelphia Campus With New State-Of-The-Art Testing Laboratory
- (09.Nov.2020) AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune's Anti-TDP-43 Antibodies Into Clinical Development
- (29.Oct.2020) WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig Alfa
- (29.Oct.2020) WuXi AppTec Reports Strong Third-Quarter 2020 Results
- (27.Oct.2020) Wuxi Biologics Unveils New PD Facility in King of Prussia, Pennsylvania
- (10.Oct.2020) Antengene Announces Collaboration With WuXi Biologics to Advance the Development of Innovative Oncology Medicines
- (09.Sep.2020) Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
- (17.Aug.2020) WuXi Biologics Records Excellent Interim Results
- (13.Aug.2020) WuXi AppTec Achieved Strong Growth in First-Half of 2020 With China Sites Resuming Full Operations
- (06.Aug.2020) WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
- (04.Aug.2020) Genuity Science Announces Strategic Collaboration With Nashville Biosciences
- (23.Jul.2020) LegoChem Names China's WuXi AppTec as Provider of Non-Clinical Trial Service
- (24.Jun.2020) Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System
- (23.Jun.2020) WuXi NextCODE Restructures and Becomes Genuity Science
- (17.Jun.2020) WuXi Biologics Selected as Winner of the 2020 Top Graduate Employers Award in China
- (15.Jun.2020) WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing
- (08.Jun.2020) WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
- (01.Jun.2020) WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit
- (18.May.2020) WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
- (18.May.2020) WuXi Biologics Closes Land Deal to Build State-Of-The-Art Biologics Production Facility in the United States
- (14.May.2020) Why Did Kolon Change Invossa Contract Manufacturer to Lonza
- (30.Apr.2020) Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody Platform
- (29.Apr.2020) WuXi AppTec Reports Solid First-Quarter 2020 Results
- (28.Apr.2020) WuXi Biologics Successfully Completes PFS Filling at Its Robotic Aseptic Filling Facility
- (22.Apr.2020) WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany